GO
| HSI1 | 25,962.73 | -426.31 | 325.39B |
| HSCEI1 | 8,691.03 | -167.60 | 91.91B |
| Back Zoom + Zoom - Block Traded | |
|
ALI HEALTH Sets Up Task Force to Centrally Direct 'B2C+O2O' Pharm Biz Segment
2026-05-15 14:22:14 ALI HEALTH (00241.HK) Chairman and CEO Shen Difan revealed at the FY2026 results analyst conference call that the company will establish a dedicated task force to centrally direct its "B2C+O2O" pharmaceutical business segment, aiming to enhance close collaboration and generate synergies while gaining insights into refined healthcare demand across tens of thousands of grids nationwide. ALI HEALTH last quoted at HKD4.23, down 6.83%, with turnover of 293 million shares, involving HKD1.259 billion. ~ AASTOCKS Financial News Website: www.aastocks.com | |